Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

99MTc-HIDA, a gallbladder imaging agent: experimental aspects

E Chiotellis, C Sawas-Dimopoulou, C Koutoulidis

    European Journal of Nuclear Medicine
    |January 1, 1978
    PubMed
    Summary

    A new technetium-99m labeled radiopharmaceutical, 99mTc-HIDA, shows rapid clearance from blood to liver and gallbladder. This agent demonstrates faster gallbladder accumulation than 131I-Rose Bengal, indicating potential for hepatobiliary imaging.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Paediatric spinal cord low-grade gliomas-evaluation and management of post-surgical residual disease.

    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery·2021
    Same author

    Synthesis and characterization of six-coordinate "3 + 2" mixed-ligand oxorhenium complexes with the o-diphenylphosphinophenolato ligand and tridentate coligands of different N and S donor atom combinations.

    Inorganic chemistry·2003
    Same author

    Oxotechnetium 99mTcO[SN(R)S][S] complexes as potential 5-HT1A receptor imaging agents.

    Nuclear medicine and biology·2002
    Same author

    Novel mixed ligand technetium complexes as 5-HT1A receptor imaging agents.

    Nuclear medicine and biology·2002
    Same author

    Softform for facial rejuvenation: historical review, operative techniques, and recent advances.

    Facial plastic surgery : FPS·2002
    Same author

    Complications of static facial suspensions with expanded polytetrafluoroethylene (ePTFE).

    The Laryngoscope·2002

    Area of Science:

    • Nuclear medicine
    • Radiopharmaceutical chemistry
    • Hepatobiliary system imaging

    Background:

    • Development of novel radiopharmaceuticals is crucial for improving diagnostic accuracy in hepatobiliary diseases.
    • Existing agents like 131I-Rose Bengal have limitations that necessitate exploration of alternatives.

    Purpose of the Study:

    • To synthesize, characterize, and evaluate the efficacy of a new 99mTc-labeled radiopharmaceutical, N-(2,6-dimethyl-phenyl-carbamoyl-methyl)-iminodiacetic acid (99mTc-HIDA), for hepatobiliary imaging.
    • To compare the pharmacokinetic profile of 99mTc-HIDA with 131I-Rose Bengal in experimental animals.

    Main Methods:

    • Synthesis and characterization of N-(2,6-dimethyl-phenyl-carbamoyl-methyl)-iminodiacetic acid (HIDA).
    • Labeling of HIDA with Technetium-99m (99mTc).

    Related Experiment Videos

  • In vivo kinetic studies in experimental animals comparing 99mTc-HIDA with 131I-Rose Bengal.

    • Main Results:

    • 99mTc-HIDA demonstrated rapid blood clearance, with subsequent accumulation in the liver, gallbladder, and excretion into the duodenum.
    • Comparative studies in rabbits showed similar blood clearance rates for 99mTc-HIDA and 131I-Rose Bengal.
    • 99mTc-HIDA exhibited significantly faster accumulation in the gallbladder compared to 131I-Rose Bengal.

    Conclusions:

    • 99mTc-HIDA is a promising new radiopharmaceutical for hepatobiliary imaging due to its favorable biodistribution and rapid clearance.
    • The agent's superior gallbladder uptake and low acute toxicity warrant further clinical investigation for diagnosing hepatobiliary disorders.